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The bacterial protein DsbD transfers reductant from the
cytoplasm to the otherwise oxidizing environment of the
periplasm. This reducing power is required for several essen-
tial pathways, including disulfide bond formation and cyto-
chrome cmaturation. DsbD includes a transmembrane domain
(tmDsbD) flanked by two globular periplasmic domains
(nDsbD/cDsbD); each contains a cysteine pair involved in elec-
tron transfer via a disulfide exchange cascade. The final step in
the cascade involves reduction of the Cys103–Cys109 disulfide of
nDsbD by Cys461 of cDsbD. Here we show that a complex
between the globular periplasmic domains is trapped in vivo
only when both are linked by tmDsbD. We have found previ-
ously (Mavridou, D. A., Stevens, J. M., Ferguson, S. J., & Redfield,
C. (2007) J. Mol. Biol. 370, 643–658) that the attacking cysteine
(Cys461) in isolated cDsbDhas a highpKa value (10.5) thatmakes
this thiol relatively unreactive toward the target disulfide in
nDsbD. Here we show using NMR that active-site pKa values
change significantly when cDsbD forms a complex with nDsbD.
This modulation of pKa values is critical for the specificity and
function of cDsbD. Uncomplexed cDsbD is a poor nucleophile,
allowing it to avoid nonspecific reoxidation; however, in com-
plex with nDsbD, the nucleophilicity of cDsbD increases per-
mitting reductant transfer. The observation of significant
changes in active-site pKa values upon complex formation has
wider implications for understanding reactivity in thiol:disul-
fide oxidoreductases.
DsbD is a unique protein that transfers reductant across the
cytoplasmic membrane to the periplasm in many Gram-nega-
tive bacteria (1, 2). Provision of reductant to the periplasm is
required because this compartment is otherwise considered to
be an oxidizing environment (2). DsbD includes three domains,
each containing a pair of cysteine residues that perform a series
of disulfide exchange reactions (Fig. 1A). In the first step, the
transmembrane domain (tmDsbD) accepts electrons from
thioredoxin in the cytoplasm; these are then transferred to
the periplasmic C-terminal domain (cDsbD) and finally to the
N-terminal domain (nDsbD), which is also located in the
periplasm (3–5). nDsbD acts as a junction point for several
pathways that require reductant, including the general disulfide
isomerase system and the pathway that is thought to reduce the
cysteine thiols of apocytochromes in the cytochrome c biogen-
esis pathway (6). In Gram-positive bacteria, CcdA, an integral
membrane protein, and ResA, which has a thioredoxin fold, pro-
vide the reductant required for cytochrome cmaturation (7).
Structural studies have sought to explain how DsbD func-
tions and interacts with its various partners. The structures of
the two soluble periplasmic domains have been determined
(Fig. 1A, left). nDsbD has an immunoglobulin-like structure (8,
9) and is the only known thiol:disulfide oxidoreductase with
this fold. cDsbD has the more typical thioredoxin fold found in
many oxidoreductases; this has the characteristic active-site
CXXC motif (10, 11). A covalent complex between single-cys-
teine variants of each of these two domains was produced in
vitro and its x-ray structure solved (12), revealing the interface
between the two domains (Fig. 1A, right). Although this mixed
disulfide is accepted as a physiological intermediate in the func-
tion of DsbD, an in vivo complex between the two soluble
domains has not been reported previously (3). Further com-
plexes between nDsbD and its other physiological partners
have also been trapped and their structures examined (9, 13).
Interestingly, all of the interaction partners of nDsbD are thi-
oredoxin-like proteins; similarities in their folds are congruous
with common interaction interfaces (14).However, only cDsbD
will reduce nDsbD, whereas nDsbD will reduce several part-
ners. This raises questions about how the direction of reductant
flow is maintained and controlled within the series of disulfide-
exchange reactions.
As part of our structural andmechanistic characterization of
DsbD and its domains in solution, we have previouslymeasured
by NMR the pKa values of the active-site cysteine pair, Cys461
and Cys464, of cDsbD (numbered according to the full-length
Escherichia coli DsbD sequence) (15). An unusually high pKa
value of 10.5 was measured for the N-terminal cysteine of the
CXXC motif, Cys461, and the pKa value of the second cysteine,
Cys464, was significantly higher than the maximum pH value
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that was studied (pH 12.2). The pKa value of 10.5 is the highest
reported for the N-terminal cysteine of the CXXC motif in a
thioredoxin fold. The striking consequence of the elevated pKa
value is that the active-site cysteine of cDsbD, Cys461, is not
strongly nucleophilic, raising critical questions about how this
cysteine reacts with the disulfide in nDsbD. It was demon-
strated using site-directed mutagenesis that the negatively
charged side chains of Asp455 and Glu468, which are located
close to the CXXC motif (Fig. 1B), are responsible for the
unusually high pKa value of Cys461; mutation of one or both of
these residues to Asn and Gln, respectively, resulted in
decreases in the pKa value of Cys461 from10.5 to 9.9 (E468Q), to
9.3 (D455N), and to 8.6 (D455N/E468Q). The pKa values for
Asp455 were found to be 5.9 and 6.6 in oxidized and reduced
cDsbD; these values are significantly higher than the value of
4 for an unperturbed aspartic acid. We postulated that the
properties of the amino acid side chains in the immediate envi-
ronment of the cysteines in cDsbD would change upon com-
plex formation with nDsbD, changing the reactivity of the cys-
teines and explaining how the reaction between the two
domains is initiated (15). Specifically, we proposed that an
increase in the pKa value of Asp455 upon complex formation
would lead to a decrease in the pKa value of Cys461, thereby
making it a better nucleophile. Stirnimann et al. (10) previously
presented pKa calculations suggesting an increase in the Asp455
pKa value upon complex formation.
The aim of this work has been to determine the molecular
basis of the control of the reactivity of the active-site cysteine
residues in cDsbD, usingNMR to compare the active-site prop-
erties of cDsbD alone and in its physiological complex with
nDsbD. We demonstrate that the pKa value of Asp455 is ele-
vated by at least 1.1 pHunitswhen cDsbD forms a complexwith
nDsbD. This modulation of the pKa value is critical for the
specificity and function of cDsbD. These in vitro studies are
complemented by in vivo studies on complex formation, in
which we have trapped the nDsbD-cDsbD complex for the first
time. The results of our experiments explain how the intramo-
lecular disulfide cascade within the soluble domains of DsbD
functions, and demonstrate the importance of the transmem-
brane domain in controlling and facilitating complex formation
between the soluble domains.
EXPERIMENTAL PROCEDURES
Construction of DsbD Plasmids—The plasmid pDzc1 was
used to express isolated wild-type cDsbD bearing a C-terminal
His6 tag and the plasmid pDzc5 a single cysteine variant
(C464A) of cDsbD with a thrombin cleavage site preceding the
C-terminal His6 tag. Isolated nDsbD with the PelB signal pep-
tide replacing the endogenous signal peptide and with a C-ter-
minal streptavidin tag was expressed from the plasmid pDzn1,
and from that a single-cysteine variant (C103A) was produced.
Finally, the full-length construct in which nDsbD and cDsbD
could be cleaved from tmDsbD (thrombin-cleavableDsbD)was
expressed from pDsbd4. Details of the production of the above
plasmids can be found in supplemental material.
Protein Production, Purification, and Characterization—All
experiments were performed in the E. coli strain BL21(DE3)
(Stratagene). All cells expressing unlabeled protein were grown
at 37 °C in 500-ml volumes of Luria Bertani (LB) broth in 2-liter
flasks from overnight starter cultures (grown at 37 °C). SDS-
PAGE analysis was carried out on 10–20% BisTris6 NuPAGE
gels (Invitrogen) with prestained proteinmarkers (SeeBlue Plus
2, Invitrogen).
OverexpressionofThrombin-cleavableDsbD—Bacteriatrans-
formed with pDsbd4 were grown with 100 g ml1 carbenicil-
lin to an A600 of 0.7 before addition of 0.5 mM isopropyl -D-
thiogalactopyranoside. After further incubation for 3 h the cells
were harvested, and the crude membrane fraction was isolated
using a French press. Disruption of the cells was performed at
16,000 p.s.i. which was followed by centrifugation at 257,000
g for 1.5 h at 4 °C. The membrane fraction was solubilized at a
protein concentration of 5 mgml1 for 1 h at 4 °C under gentle
6 The abbreviations used are: BisTris, 2-[bis(2-hydroxyethyl)amino]-2-
(hydroxymethyl)propane-1,3-diol; DDM, n-dodecyl -D-maltoside; HRP,
horseradish peroxidase; HSQC, heteronuclear single quantum coherence.
FIGURE 1. Schematic representation ofDsbD.A,proposed pathway of elec-
tron flow from thioredoxin (TrxA) in the cytoplasm, via the three domains of
DsbD, to the cytochrome c maturation (Ccm) and disulfide bond isomeriza-
tion pathways in the periplasm is shown. The crystal structure of nDsbD is
from Protein Data Bank code 1L6P (8), cDsbD from Protein Data Bank code
1UC7 (11), and the nDsbD-cDsbD complex fromProteinData Bank code 1VRS
(12). The cyan boxes indicate the thrombin cleavage sites introduced into
full-length DsbD to allow detection of the nDsbD-cDsbD complex following
its formation in vivo. The cysteine residues are shown in yellow. B, schematic
representation of the active site of cDsbD in the covalent complex with
nDsbD (12). Someactive-site residues of cDsbDare indicated in stick represen-
tation and the inter-domain disulfide (Cys461–SS–Cys109) is shown in yellow.
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agitation in 20mMTris-HCl, 300mMNaCl, 20%v/v glycerol, 1%
w/v n-dodecyl -D-maltoside (DDM) (Anatrace) (pH 7.5).
Unsolubilized material was removed by centrifugation at
257,000 g for 45 min at 4 °C. The supernatant was applied to
10 ml of Fast Flow Chelating-Sepharose (Amersham Bio-
sciences) charged with Ni2. The column was washed with 20
mM Tris-HCl, 150 mM NaCl, 20 mM imidazole, 0.1% w/v DDM
(pH 7.5), and the bound protein was eluted with 20 mM Tris-
HCl, 150mMNaCl, 200mM imidazole, 0.1%w/vDDM (pH7.5).
A concentrated protein solution of 0.5 ml was applied to a
Superdex 200 (HR) size-exclusion column (GE Healthcare)
equilibrated in 20mMTris-HCl, 150mMNaCl, 0.03%w/vDDM
(pH 7.5). The purest fractions were pooled and concentrated to
0.5ml. Toprevent artifactual thiol-disulfide exchange reactions
from occurring during the thrombin cleavage, free thiols were
alkylated withN-ethylmaleimide (Sigma) (16). Purified protein
was incubated in the presence of 30 mM N-ethylmaleimide for
1 h at room temperature. After removal of the excess alkylating
reagent, the protein was cleaved using the thrombin Clean-
Cleave kit according to the manufacturer’s instructions
(Sigma). The presence of the nDsbD-cDsbD mixed disulfide
was confirmed byWestern blotting using two primary antibod-
ies as follows: 1) penta-His HRP-conjugated monoclonal anti-
body (Qiagen), and 2) goat antiserum raised against the cDsbD
sequence of E. coli DsbD and donkey anti-sheep alkaline phos-
phatase-conjugated antibody (Sigma), as primary and second-
ary antibodies, respectively.
Characterization of the nDsbD-cDsbD Mixed Disulfide
Formed in Vivo—The covalent complex between nDsbD and
cDsbD was N-terminally sequenced from protein samples in
SDS-polyacrylamide gels that were electrophoretically trans-
ferred to a polyvinylidene difluoride membrane and stained
with Coomassie Brilliant Blue. The protein bands were excised
and subjected to automated Edman sequencing using an
Applied Biosystems 494A Procise protein sequencer.
Simultaneous Overexpression of nDsbD and C464A-cDsbD—
Bacteria transformed with pDzn1 and pDzc5 were grown with
100 g ml1 ampicillin and 20 g ml1 gentamycin to an A600
of 1.2 before addition of 1 mM isopropyl -D-thiogalactopyran-
oside. After further incubation for 4 h, the cells were harvested
spheroplasted as described (17) omitting EDTA.Western blot-
ting of the extracted periplasm for the detection of the nDsbD-
cDsbD mixed disulfide complex was done using two primary
antibodies as follows: 1) StrepMAB-Classic HRP-conjugated
monoclonal antibody (IBAGmbH), and 2) penta-HisHRP-con-
jugated monoclonal antibody (Qiagen).
Production and Purification of the C103A-nDsbD-15N-
C464A-cDsbDComplex for NMR Studies—Themixed disulfide
complex was formed in vitro using C103A-nDsbD and uni-
formly 15N-labeled C464A-cDsbD purified separately from
BL21(DE3) cells (Stratagene). For the production of C103A-
nDsbD, cells transformedwith pDzn2were grown at 30 °Cwith
20 g ml1 gentamycin to an A600 of 1.5 before addition of 1
mM isopropyl-D-thiogalactopyranoside. After further incuba-
tion for 4 h at 37 °C the cells were harvested and spheroplasted
as described (17) omitting EDTA. The periplasmic fraction was
applied to 5 ml of Strep-Tactin-Sepharose (IBA GmbH) equil-
ibrated with 50 mM Tris-HCl, 150 mM NaCl (pH 7.5). The col-
umn was washed with 50 mM Tris-HCl, 1 M NaCl (pH 7.5), and
the protein was eluted with 50 mM Tris-HCl, 150 mMNaCl, 2.5
mM desthiobiotin (IBA GmbH) (pH 7.5) according to the man-
ufacturer’s instructions. Production and purification of 15N-
labeled C464A-cDsbD were done in the same way as for wild-
type cDsbD, as described in previous work (15).
The C103A-nDsbD-15N-C464A-cDsbD mixed disulfide
complex was prepared using a reported method (12). First,
C103A-nDsbD was mixed with 10 mM dithiobisnitrobenzoic
acid (Sigma) at 25 °C for 30min. After removal of excess dithio-
bisnitrobenzoic acid, it was mixed with equimolar 15N-C464A-
cDsbD and incubated as above. The reactionmixture was puri-
fied by two affinity chromatography steps, each specific to one
of the domains. The mixture was applied to 3 ml of Fast Flow
Chelating-Sepharose (Amersham Biosciences) charged with
Ni2and purified as described previously (15). After removing
the imidazole, the protein solution was applied to 3ml of Strep-
Tactin-Sepharose (IBA GmbH) and was purified as described
above for C103A-nDsbD. The nDsbD-15N-cDsbD mixed-dis-
ulfide sample was of high purity as assessed using SDS-PAGE
(supplemental Fig. S1A), and its correct molecular weight
was verified by electrospray ionization-mass spectrometry
(expected mass, 33,187 Da; observed mass, 33,185 Da).
Production and Purification of the 15N-labeled Wild Type
and C464A-cDsbD—15N-Labeled wild-type cDsbD and
C464A-cDsbD were used as control proteins for the pH titra-
tion of the nDsbD-15N-cDsbD mixed disulfide. Both proteins
were produced and purified as described previously (15).
pHTitration of the nDsbD-15N-cDsbDMixedDisulfide Using
NMR Spectroscopy—The 1HN and 15N resonances of C464A-
cDsbD as a separate domain and in the nDsbD-15N-cDsbD
mixed disulfide were assigned using uniformly 15N-labeled
samples of 0.8 mM protein for the isolated domains and 0.5 mM
protein for the mixed disulfide, in 95% H2O, 5% D2O at pH 6.5.
Assignments for C464A-cDsbD in the isolated domain and in
the nDsbD-15N-cDsbD complex were obtained by comparison
of three-dimensional 15N-edited nuclear Overhauser effect
spectroscopy-HSQC and total correlation spectroscopy-HSQC
spectra with the previously assigned spectra of reduced wild-
type cDsbD (15).
NMR experiments for the determination of the pKa values of
Asp455 in the active-site of cDsbD in the nDsbD-15N-cDsbD
mixed disulfide were performed using 0.5 mM of complex in
95%H2O, 5%D2O.Determination of the pKa values ofAsp455 in
the active-site of 15N-labeled wild-type cDsbD and C464A-
cDsbDwas done in the sameway as a control experiment. In the
case of the 15N-labeledwild-type cDsbD, the sample was a1:1
mixture of oxidized and reduced protein allowing simultaneous
measurement of the pKa value for the two oxidation states. The
pH of solutions was adjusted by using small volumes of 0.1–1 M
HCl or 0.1–1 M NaOH. The pH of the samples was measured
before and after each experiment, and the average of the two
measurements was used for data analysis. The pH values given
are direct pH meter readings measured at room temperature.
Two-dimensional 1H-15N HSQC spectra were collected at
313 K on a home-built 750-MHz NMR spectrometer, which
is controlled with GE/Omega software and is equipped with
a home-built triple-resonance pulsed-field gradient probe-
Control of Disulfide Exchange in DsbD
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head. Sweep widths of 9345.79 Hz and 2500 were used in F2
(1H) and F1 (15N), respectively. 128 complex 15N increments
of 8, 12, and 96 scans were collected with 1024 complex
points in the acquisition dimension for 15N-labeled wild-
type cDsbD, C464A-cDsbD, and the nDsbD-15N-cDsbD
mixed disulfide complex, respectively. NMR data were pro-
cessed and visualized using NMRPipe, NMRDraw, and
NMRView (18, 19). Peak picking was carried out using in-
house software.
pH Titration of [3-13C]Cysteine-labeled Wild Type and
D455N-cDsbD—1H-13CHSQCexperiments for the determina-
tion of the pKa value of Cys461 at 313 K were performed on
solutions containing1.5 mM of [3-13C]cysteine-labeled wild-
type or D455N cDsbD in 99% D2O as described previously at
298K (15). Dithiothreitol was added tomaintain the proteins in
the reduced state.
Data Fitting—pKa values for Asp455 were determined from
1HN or 15N chemical shifts measured as a function of pH. pKa
values for Cys461 were determined from 1H or 13C chemical
shifts measured as a function of pH. The titration data were
fitted to either one or two pKa curves (20) using in-house soft-
ware as described previously (15). The pKa value for Asp455 was
determined from the pH dependence of five chemical shift val-
ues (Asp455/Glu468 1HN and 15N and Gln488 15N). The pKa
value for Cys461 was determined from the pH dependence of
four to six chemical shift values (Cys461/Cys464 1H and 13C).
Errors in the pKa values were estimated as the standard devi-
ation from the mean pKa value. Details of the parameters
obtained in each fit are listed in supplemental Tables S1 and
S2.
RESULTS
In Vivo Studies of the Formation of an nDsbD-cDsbD Com-
plex in Full-length DsbD—We have used a thrombin-cleavable
variant of DsbD (Fig. 1A) to attempt to identify a mixed-disul-
fide complex of nDsbD and cDsbD in vivo. This construct
expresses full-length DsbD in which nDsbD and cDsbD can
each be cleaved from the transmembrane domain by virtue of
engineered thrombin cleavage sites. The C464A mutation in
cDsbDwas introduced in an attempt to trap the nDsbD-cDsbD
mixed-disulfide complex because Cys464 is believed to be
responsible for driving the cleavage of the interdomain disul-
fide and the final transfer of reductant from cDsbD to nDsbD
(12). Thrombin-cleavable DsbD was expressed, purified, incu-
bated with N-ethylmaleimide to alkylate its free thiols, incu-
bated with thrombin, and analyzed by SDS-PAGE andWestern
blotting with antibodies against the His6 tag and cDsbD; the
results of theWestern blotting are shown in Fig. 2. It can be seen
in Fig. 2, lanes 6, 7, 14, and 15, that a band of the expected
molecular weight for an nDsbD-cDsbD mixed disulfide (32
kDa) appeared after thrombin cleavage of thrombin-cleavable
DsbD (box II). No band can be seen at this position before
thrombin cleavage (Fig. 2, lanes 5 and 13). The32-kDa band
disappears in the presence of reductant (Fig. 2, lanes 8 and 16),
confirming that it is a covalent complex containing a disulfide
bond. The 32-kDa covalent complex from the SDS-PAGE
band was N-terminally sequenced, and both the nDsbD
((M)LFDAPGRSQ) and cDsbD (GSGQTHLNFT) termini were
detected. As seen in Fig. 2, lanes 6 and 7 or 14 and 15, the band
corresponding to the complex is presentwhether or not the free
FIGURE 2. Western blots of purified full-length C464A thrombin-cleavable DsbD before and after thrombin cleavage. Penta-His HRP-conjugated
antibody was used in lanes 1–8 and goat antiserum raised against cDsbD of E. coli DsbD was used in lanes 9–16. Lanes 1, 4, 9, and 12 show molecular mass
markers (from the top these are 49, 38, 28, and 14 kDa); lanes 2 and 10 show the negative control (nDsbDwith no affinity tag); lanes 3 and 11 show the positive
control (cDsbD bearing a C-terminal His6 tag). C464A thrombin-cleavable DsbD is shown in lanes 5 and 13 before alkylation of free thiols (A) and thrombin
cleavage (T), in lanes 6and14without alkylationandafter thrombincleavage, in lanes 7and15after alkylationand thrombincleavage, and in lanes 8and16after
alkylation and thrombin cleavage in the presence of reductant (R). The cDsbD band can be seen at14 kDa in lanes 3 and 11, and in 6–8 and 14–16 in Box III
(this construct runs as a diffuse double band on SDS-PAGE because its PelB signal sequence, which targets the protein to the periplasm, is cleaved inefficiently
by the signal peptidase, leaving a large fractionof theprotein uncleaved (confirmedbymass spectrometry andN-terminal sequencing)). TheuncleavedC464A
thrombin-cleavable DsbD band can be seen at 49 kDa (the actual mass of the protein is 60.8 kDa; a difference between the two masses is common for
membrane proteins) in lanes 5–8 and 13–16 (box I) along with another band at28 kDa that is a contaminant commonly seen after the purification of this
protein. The nDsbD-cDsbDmixed disulfide band can be seen at32 kDa in lanes 6, 7, 14, and 15 (box II) and it disappears in the presence of reductant in lanes
8 and 16. 2–3 g of total protein were loaded in each lane.
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thiols of the protein were alkylated before thrombin cleavage.
Incubation with N-ethylmaleimide, therefore demonstrates
that this complex was formed before cleavage of the full-length
protein. A band for the full-length thrombin-cleavable DsbD
can be seen (at49 kDa) even after thrombin cleavage (Fig. 2,
lanes 6–8 and 14–16, box I); this is attributed to inefficient
thrombin cleavage because of the presence of the detergent
DDM in the protein solutions. It is also likely that the presence
of the protein in the detergent micelle could reduce the acces-
sibility of the protease cleavage sites to the thrombin (21).
Moreover, a C464A-cDsbDband can be seen (at14 kDa) after
thrombin cleavage even in the absence of reductant (Fig. 2,
lanes 6, 7, 14, and 15, box III). This is observed because there are
molecules in the protein sample in which the nDsbD-cDsbD
mixed disulfide had not formed and for which the thrombin
cleavage led to release of the two separate periplasmic domains
(isolated nDsbDcannot be seen in theWestern blot because it is
not His6-tagged).
In Vivo Studies of Complex Formation between Isolated
nDsbD and cDsbD—To assess the role of tmDsbD inmediating
the interaction between nDsbD and cDsbD, the two periplas-
mic domains of DsbD, nDsbD bearing a C-terminal streptavi-
din tag and aC464Avariant of cDsbDbearing aC-terminalHis6
tag, were overexpressed simultaneously as soluble proteins
exported to the periplasm. The C464Amutation in cDsbD was
used for reasons described above. The periplasmic extract
was analyzed by SDS-PAGE and Western blotting with anti-
bodies against the streptavidin tag, to detect nDsbD, and
against a penta-histidine sequence, to detect cDsbD. The
nDsbD-cDsbD mixed disulfide is expected to migrate on SDS-
PAGE between the 28- and 38-kDa molecular mass markers
and to be detected by both antibodies (Fig. 3). No band corre-
sponding to the nDsbD-cDsbD mixed disulfide was observed in
Fig. 3, lanes 4 and 8. In Fig. 3, lane 4, only the nDsbD band at17
kDa is observed, and in lane 8 theC464A-cDsbDbandat14kDa
and a band corresponding to its homodimer at 33 kDa (con-
firmed byWestern blotting, not shown) are observed.
A possible explanation for the failure of the nDsbD-cDsbD
mixed-disulfide complex to form in vivo is that the proteins
were present in the incorrect oxidation states for disulfide bond
formation to occur; interdomain disulfide bond formation
requires the presence of oxidized nDsbD and reduced C464A-
cDsbD. NMR studies of periplasmically overexpressed nDsbD
show that it is present predominantly in the oxidized form.
cDsbD cannot form an intramolecular disulfide bond because it
has a single cysteine and the homodimer is observed as only a
minor species (Fig. 3, lane 8). For these reasons, attack of the
cDsbD cysteine thiol on the disulfide of nDsbD, as occurs in the
physiological pathway, should have beenpossible.We therefore
conclude that a complex between soluble nDsbD and cDsbD,
co-expressed in the E. coli periplasm, does not form in the
absence of the transmembrane domain that usually connects
the two domains in the full-length protein.
NMR Analysis of the nDsbD-15N-cDsbD Mixed-disulfide
Complex—A mixed-disulfide complex was produced using
purified single-cysteine variants of nDsbD (C103A) and cDsbD
(C464A) to ensure that the physiologically relevant disulfide
was formed (Cys461–SS–Cys109), to avoid any cleavage of this
disulfide because of the presence of Cys464 and to eliminate any
complications during the pKa determination of Asp455 caused
by the titration of the Cys464 or Cys103 thiols in the active site.
NMR spectroscopy allows measurement of the pKa value of
Asp455 in the active site of cDsbD when cDsbD is in close prox-
imity to its periplasmic partner nDsbD. For this purpose we
used uniformly 15N-labeled C464A-cDsbD covalently linked to
unlabeled C103A-nDsbD, thus producing a C103A-nDsbD-
15N-C464A-cDsbD covalent complex (subsequently referred to
as nDsbD-15N-cDsbD) where only cDsbD gives NMR signals in
the 1H-15NHSQC spectrum but in which it is influenced by the
presence of nDsbD. In this way we were able to simplify the
NMR spectrumof a relatively large (32-kDa) protein complex
and to focus on the domain of interest.
Previous studies of isolated cDsbDwere carried out at 298 K.
The 1H-15N HSQC spectrum of the nDsbD-15N-cDsbD com-
plex at 298 K is significantly broader, because of the higher
molecular weight of the complex, than that of isolated cDsbD,
andmanyof the expected peaks are not observed (supplemental
Fig. S1, D and E). A significant improvement in the quality of
the HSQC spectrum of the complex was observed at 313 K
(supplemental Fig. S1F); at this temperature all expected peaks
from cDsbD are observed. Both nDsbD and cDsbD have rela-
tively high thermal stabilities and are completely folded and
native at 313K (supplemental Fig. S1B). The pH titration exper-
iments described below were therefore performed at 313 K.
pKa Determination for Asp455 in the nDsbD-15N-cDsbD
Complex—We have monitored, between pH 4 and pH 10, the
15N and 1HN chemical shifts of the backbone amides of Asp455
andGlu468 and the side chain 15N ofGln488 inHSQC spectra of
the nDsbD-15N-cDsbD mixed-disulfide complex (Fig. 4A).
These shifts are all sensitive to titration of Asp455 because of a
hydrogen bond network involving Asp455, Glu468, and Gln488
FIGURE 3. Western blots of periplasmic extracts of E. coli expressing
nDsbD with a streptavidin tag and C464A-cDsbD with a His6 tag.
StrepMAB-ClassicHRP-conjugated antibodywas used in lanes 1–4 andpenta-
His HRP-conjugated antibody was used in lanes 5–8. Lanes 1 and 5 show
molecularmassmarkers; lanes 2 and 6 show thenegative control (nDsbDwith
no affinity tag); lanes 3 and 7 show positive controls (full-length DsbD with a
C-terminal streptavidin tag and cDsbD with a C-terminal His6 tag, respec-
tively), and lanes 4 and 8 show the periplasmic extract. The full-length DsbD
band can be seen at49 kDa in lane 3 alongwith a small amount of contam-
inant at28 kDa (see explanation in Fig. 2). The nDsbD band can be seen at
17 kDa in lane 4 and the cDsbD band can be seen at14 kDa (the diffuse
double band is explained in Fig. 2) in lanes 7 and 8 along with the band of its
homodimer at33 kDa. 15–20 g of total protein were loaded in each lane.
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(10, 11). We have shown previously that cDsbD is stable
between pH 4 and 12 (15). 1H NMR spectra of the complex
collected between pH 4 and 10 demonstrate that nDsbD in the
complex is also stable over this pH range (supplemental Fig.
S1C). Analysis of the pH dependence of the 15N and 1HN chem-
ical shifts of Asp455 and Glu468 and of the side chain 15N of
Gln488 gave an average pKa value of 8.5 0.1 for Asp455 (Fig. 5,
A–C). This pKa value is significantly higher than the values of
5.9  0.1 and 6.6  0.1 obtained previously for Asp455 in
reduced and oxidized cDsbD (15).Our previous study of cDsbD
was carried out at 298 K, whereas the spectra of the complex
were collected at 313 K. As a control, we have monitored the
same chemical shifts in uniformly 15N-labeledwild-type cDsbD
at 313 K. The experiment was performed, as before (15), in a
mixed oxidation state sample, and we obtained a pKa value of
6.5 0.1 in the reduced state and of 7.0 0.1 for Asp455 in the
oxidized state (Fig. 5, A–C). These values are 0.5 pH units
higher than the values measured at 298 K but are nevertheless
still significantly lower than the value of 8.5 measured for
Asp455 in the nDsbD-15N-cDsbD complex. To ensure that the
difference in the pKa values of Asp455 between complexed and
uncomplexed cDsbD is not an effect of theC464Amutation, we
have also performed the titration for uniformly 15N-labeled
FIGURE 4. Overlay of two-dimensional 1H-15N HSQC spectra of the
nDsbD-15N-C464A-cDsbD complex (A) and 15N-C464A-cDsbD collected
at 750 MHz and 313 K for pH values ranging from 4 to 10 (B). For the
nDsbD-15N-C464A-cDsbD complex, spectra collected at pH 4.635 (light gray),
5.09 (dark gray), 5.73 (black), 6.57 (red), 7.165 (orange), 7.55 (yellow), 8.00
(green), 8.43 (blue-green), 8.845 (cyan), 9.32 (blue), and 9.755 (violet) are
shown. For 15N-C464A-cDsbD, spectra collected at pH 4.36 (light gray), 4.895
(dark gray), 5.53 (black), 6.075 (red), 6.61 (orange), 7.21 (yellow), 7.685 (green),
8.155 (blue-green), 8.61 (cyan), 9.11 (blue), and 9.86 (violet) are shown. The
black lines drawn in A and B trace the pH-dependent chemical shift changes
observed for Asp455.
FIGURE 5.Measurement of the pKa value of the active-site residueAsp
455
from the pH dependence of the 15N chemical shift of Asp455 (A), the 15N
chemical shift of Glu468 (B), and the 15N chemical shift of Gln488 (C). Plots
are shown for the nDsbD-C464A-cDsbD complex (F), isolated C464A-cDsbD
(), and for oxidized () and reduced (‚) isolated wild-type cDsbD. The con-
tinuous lines show the best fit to a single pKa value or to two pKa values for
each dataset. The fitting procedure has been described previously (15); see
supplemental Table S1 for a summary of the fitted parameters.
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C464A-cDsbD at 313 K and obtained an average pKa value of
7.4 0.1 for Asp455 (Fig. 4B and Fig. 5, A–C). Therefore, it can
be concluded that the pKa value of Asp455 is elevated by at least
1.1 pH units when cDsbD forms a complex with nDsbD.
pKa Determination for Cys461 at 313 K—The pKa value for
Cys461 was measured for wild-type cDsbD and for the D455N
variant of cDsbD at 313 K for direct comparison with the pKa
values measured above for Asp455 in the nDsbD-15N-cDsbD
complex at 313 K. Analysis of the pH dependence of the 13C
and 1H chemical shifts of Cys461 and Cys464 in cDsbD gives
pKa values of 10.4  0.1 and 9.2  0.2 for Cys461 in wild-type
andD455N cDsbD, respectively (supplemental Fig. S2 and sup-
plemental Table S2). These values agree within experimental
error with the values of 10.5  0.1 and 9.3  0.05 reported
previously at 298 K. Therefore, the pKa value of Cys461 does not
show a temperature dependence.
DISCUSSION
It has long been known that DsbD functions by interaction
between the cysteine pairs in its three domains, although how
these interactions occur within this protein, in which one of the
three domains is membrane-embedded, has remained elusive.
In this study we have used both in vivo and in vitro approaches
to understand how the interaction and reaction between the
two soluble domains are controlled. We have demonstrated
usingWestern blotting that a covalent nDsbD-cDsbD complex
can be trapped in vivowhen full-length DsbD is overexpressed.
This result proves that the nDsbD-cDsbD interaction, which
has previously only been probed in vitro (12), is physiologically
relevant. No such complex was detected when the individual
domains, nDsbD and cDsbD, were co-expressed in the
periplasm.
The fact that the nDsbD-cDsbD complex was not detectable
in the absence of the linking tmDsbD has important implica-
tions for the function of the membrane-embedded domain.
The latter is known to interact with, and acquire reductant
from, cytoplasmic thioredoxin and so effectively performs the
transmembrane reductant transfer reaction (22). In addition, it
appears to have an important function in ensuring the proxim-
ity and correct orientation of the two periplasmic domains. It
should be noted that the interaction interface identified in the
nDsbD-cDsbD crystal structure is not very extensive and
involves a relatively small number of interactions (12). This
limited interface may result in a relatively low affinity interac-
tion between nDsbD and cDsbD. Therefore, the transmem-
brane domainmay be essential to ensure the high local concen-
tration of the domains that would be required for the formation
of a complex and subsequent electron transfer via the disulfide
exchange reaction.
In isolated cDsbD, Cys461, which catalyzes reduction of the
Cys103–Cys109 disulfide in nDsbD, has a pKa value of 10.4 at 313
K; this elevated valuemakesCys461 a poor nucleophile. The pKa
value of Cys461 must therefore be lowered when it approaches
nDsbD to make it more reactive. The high pKa value for Cys461
results from its close proximity to Asp455 and Glu468 in the
active site. Here we have used the covalent nDsbD-15N-cDsbD
complex tomeasure the pKa value ofAsp455 in cDsbDwhen it is
in close contact with nDsbD. We found that the pKa value of
Asp455 is elevated by at least 1.1 pH units to a value of 8.5 in the
complex at 313 K. At pH 7.0, the ratio of deprotonated (nega-
tively charged) to protonated (uncharged) Asp455 in the com-
plex will be 0.03:1. In effect, the carboxyl side chain of Asp455 is
fully protonated. This will have a similar effect as the D455N
mutation that we have found previously leads to a 1.2 pH unit
decrease in the pKa value of Cys461 (from 10.4 to 9.2 at 313 K)
(15). Therefore, we conclude that when nDsbD and cDsbD
form a complex, a reduction in the pKa of Cys461 by at least 1.2
pHunits to a value of9.2 will take place. The concentration of
the thiolate form of Cys461 will increase16-fold at physiolog-
ical pH making this cysteine a better nucleophile.
This experimental result is broadly consistent with previous
electrostatic calculations carried out using x-ray structures,
which predicted pKa values of 4.8 and 9.9 for Asp455 in the
isolated cDsbD and the nDsbD-cDsbD complex, respectively
(10). It should be noted that such calculations are extremely
sensitive to small differences in x-ray structures; the program
PROPKA gives predicted pKa values for Asp455 of 9.6, 7.0, and
7.7 using the three nDsbD-cDsbDmolecules in the asymmetric
unit (23). A pKa value of 5.4 is predicted by PROPKA for Asp455
in isolated reduced cDsbD. The increase in the predicted pKa
value for Asp455 in the complex arises from an increase in the
desolvation of the side chain of Asp455 and from an increased
charge-charge contribution from Glu468 as this residue
becomes more buried in the complex (23).
The side chains of Cys461 andAsp455 are in close proximity in
the active site of cDsbD. These residues are homologous to
Cys32 and Asp26 in thioredoxin; microscopic pKa values of 7.5
and 9.2 must be invoked to explain their titration behavior in
thioredoxin (24, 25). If Asp26 titrates first with a pKa of 7.5, then
Cys32 in the same molecule will have a pKa value of 9.2. Con-
versely, if Cys32 titrates with a pKa of 7.5, then Asp26 will have
an elevated pKa of 9.2. In isolated and reduced cDsbD micro-
scopic pKa values are not relevant because the measured pKa
values of 6.5 and 10.4 for Asp455 and Cys461, respectively, at 313
K differ so significantly (15). However, when cDsbD comes into
contactwith nDsbD, and the pKa value ofAsp455 is raised to 8.5,
microscopic pKa valuesmay need to be considered. In this case,
if Asp455 titrates first with a pKa of 8.5, then Cys461 in the same
molecule will have a pKa of 10.4. However, if Cys461 titrates
first it will have a pKaof 8.5, andAsp455will have a pKaof10.4.
In the latter case, Cys461 is significantly more reactive than in
isolated cDsbD (80-fold increase in the concentration of the
thiolate form of Cys461). This proposed lowering of the Cys461
pKa cannot be confirmed experimentally by NMR because
nDsbD and cDsbD do not form at stable high affinity complex
in the absence of a mixed disulfide involving Cys461.
The elevated pKa value of 10.4 for Cys461 in isolated cDsbD
has the advantage of protecting cDsbD from nonspecific reoxi-
dation, for example, by the powerful periplasmic oxidase DsbA.
When cDsbD and nDsbD interact, the pKa value of Cys461 is
lowered leading to an increase in the nucleophilic character of
this residue. Asp455 is only able to exert this control over the
reactivity of Cys461 in cDsbD because it is buried and already
has a relatively high pKa value (6) in the isolated domain.
Thus, modulation of active-site pKa values resulting from
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changes in the environment of the active site is key to the spec-
ificity of cDsbD.
Similar perturbations to pKa values may occur in the active
sites of other thioredoxin-like oxidoreductases. A general acid/
base catalytic mechanism has been proposed for E. coli thiore-
doxin on the basis of pKa values measured for the isolated pro-
tein (26). In the final step of the mechanism, the deprotonated
carboxyl group of Asp26 (which is the structural counterpart of
Asp455 in cDsbD) is proposed to abstract a proton from the thiol
of Cys35, either directly or via a bridging water molecule (27),
and the resulting thiolate attacks the mixed disulfide to form
the reduced substrate and oxidized thioredoxin. A similar role
for the analogous Asp/Glu is suggested in other thiol:disulfide
oxidoreductases (26). The pKa value of 6.5measured for Asp455
in isolated cDsbD suggests it could play a similar role. However,
the elevated pKa value of 8.5 for Asp455 in the nDsbD-cDsbD
complex makes this role unlikely. Other acidic groups in prox-
imity to the thiol group of Cys464, such as Glu468, may play this
role in cDsbD. An alternative mechanism for thioredoxin has
been proposed in which the thiolate group in the substrate pro-
tein abstracts the proton from Cys35 (28, 29); this mechanism
would also depend on the pKa value of the substrate thiol in the
complex. Our results highlight the importance of considering
the effects of protein-protein interactions in physiological com-
plexes on the properties of active-site residues rather than sim-
ply considering protein domains in isolation.
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